SEARCH

SEARCH BY CITATION

References

  • Adlerz L., Holback S., Multhaup G. and Iverfeldt K. (2007) IGF-1-induced processing of the amyloid precursor protein family is mediated by different signaling pathways. J. Biol. Chem. 282, 1020310209.
  • Ahmad M., Takino T., Miyamori H., Yoshizaki T., Furukawa M. and Sato H. (2006) Cleavage of amyloid-beta precursor protein (APP) by membrane-type matrix metalloproteinases. J. Biochem. 139, 517526.
  • Alfa Cisse M., Sunyach C., Slack B. E., Fisher A., Vincent B. and Checler F. (2007) M1 and M3 muscarinic receptors control physiological processing of cellular prion by modulating ADAM17 phosphorylation and activity. J. Neurosci. 27, 40834092.
  • Allinson T. M., Parkin E. T., Condon T. P., Schwager S. L., Sturrock E. D., Turner A. J. and Hooper N. M. (2004) The role of ADAM10 and ADAM17 in the ectodomain shedding of angiotensin converting enzyme and the amyloid precursor protein. Eur. J. Biochem. 271, 25392547.
  • Allsop D., Yamamoto T., Kametani F., Miyazaki N. and Ishii T. (1991) Alzheimer amyloid beta/A4 peptide binding sites and a possible ‘APP-secretase’ activity associated with rat brain cortical membranes. Brain Res. 551, 19.
  • Almkvist O., Basun H., Wagner S. L., Rowe B. A., Wahlund L. O. and Lannfelt L. (1997) Cerebrospinal fluid levels of alpha-secretase-cleaved soluble amyloid precursor protein mirror cognition in a Swedish family with Alzheimer disease and a gene mutation. Arch. Neurol. 54, 641644.
  • Amour A., Slocombe P. M., Webster A. et al. (1998) TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett. 435, 3944.
  • Amour A., Knight C. G., Webster A., Slocombe P. M., Stephens P. E., Knauper V., Docherty A. J. and Murphy G. (2000) The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett. 473, 275279.
  • Anders A., Gilbert S., Garten W., Postina R. and Fahrenholz F. (2001) Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases. FASEB J. 15, 18371839.
  • Anderson J. P., Esch F. S., Keim P. S., Sambamurti K., Lieberburg I. and Robakis N. K. (1991) Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cells. Neurosci. Lett. 128, 126128.
  • Arikkath J. and Reichardt L. F. (2008) Cadherins and catenins at synapses: roles in synaptogenesis and synaptic plasticity. Trends Neurosci. 31, 487494.
  • Arribas J. and Massague J. (1995) Transforming growth factor-alpha and beta-amyloid precursor protein share a secretory mechanism. J. Cell Biol. 128, 433441.
  • Arribas J., Coodly L., Vollmer P., Kishimoto T. K., Rose-John S. and Massague J. (1996) Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J. Biol. Chem. 271, 1137611382.
  • Asai M., Hattori C., Szabo B., Sasagawa N., Maruyama K., Tanuma S. and Ishiura S. (2003) Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase. Biochem. Biophys. Res. Commun. 301, 231235.
  • Baker A. H., Edwards D. R. and Murphy G. (2002) Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell Sci. 115, 37193727.
  • Baki L., Marambaud P., Efthimiopoulos S. et al. (2001) Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex. Proc. Natl. Acad. Sci. USA 98, 23812386.
  • Bernstein H. G., Bukowska A., Krell D., Bogerts B., Ansorge S. and Lendeckel U. (2003) Comparative localization of ADAMs 10 and 15 in human cerebral cortex normal aging, Alzheimer disease and Down syndrome. J. Neurocytol. 32, 153160.
  • Black R. A., Rauch C. T., Kozlosky C. J. et al. (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385, 729733.
  • Blacker M., Noe M. C., Carty T. J., Goodyer C. G. and LeBlanc A. C. (2002) Effect of tumor necrosis factor-alpha converting enzyme (TACE) and metalloprotease inhibitor on amyloid precursor protein metabolism in human neurons. J. Neurochem. 83, 13491357.
  • Blobel C. P. (2005) ADAMs: key components in EGFR signalling and development. Nat. Rev. Mol. Cell Biol. 6, 3243.
  • Buxbaum J. D., Koo E. H. and Greengard P. (1993) Protein phosphorylation inhibits production of Alzheimer amyloid beta/A4 peptide. Proc. Natl. Acad. Sci. USA 90, 91959198.
  • Buxbaum J. D., Liu K. N., Luo Y., Slack J. L., Stocking K. L., Peschon J. J., Johnson R. S., Castner B. J., Cerretti D. P. and Black R. A. (1998) Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273, 2776527767.
  • Caccamo A., Oddo S., Billings L. M., Green K. N., Martinez-Coria H., Fisher A. and LaFerla F. M. (2006) M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron 49, 671682.
  • Caille I., Allinquant B., Dupont E., Bouillot C., Langer A., Muller U. and Prochiantz A. (2004) Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricular zone. Development 131, 21732181.
  • Caporaso G. L., Gandy S. E., Buxbaum J. D., Ramabhadran T. V. and Greengard P. (1992) Protein phosphorylation regulates secretion of Alzheimer beta/A4 amyloid precursor protein. Proc. Natl. Acad. Sci. USA 89, 30553059.
  • Carey R. M., Blusztajn J. K. and Slack B. E. (2011) Surface expression and limited proteolysis of ADAM10 are increased by a dominant negative inhibitor of dynamin. BMC Cell Biol. 12, 20.
  • Checler F. (1995) Processing of the beta-amyloid precursor protein and its regulation in Alzheimer’s disease. J. Neurochem. 65, 14311444.
  • Cisse M. A., Sunyach C., Lefranc-Jullien S., Postina R., Vincent B. and Checler F. (2005) The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity. J. Biol. Chem. 280, 4062440631.
  • Cisse M., Braun U., Leitges M., Fisher A., Pages G., Checler F. and Vincent B. (2011a) ERK1-independent alpha-secretase cut of beta-amyloid precursor protein via M1 muscarinic receptors and PKCalpha/epsilon. Mol. Cell. Neurosci. 47, 223232.
  • Cisse M., Duplan E., Guillot-Sestier M. V., Rumigny J., Bauer C., Pages G., Orzechowski H. D., Slack B. E., Checler F. and Vincent B. (2011b) The extracellular regulated kinase-1 (ERK1) controls regulated {alpha}-secretase-mediated processing, promoter transactivation and mRNA levels of the cellular prion protein. J. Biol. Chem. 286, 2919229206.
  • Clement A. B., Hanstein R., Schroder A., Nagel H., Endres K., Fahrenholz F. and Behl C. (2008) Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress. Neuroscience 152, 459468.
  • Copanaki E., Chang S., Vlachos A., Tschape J. A., Muller U. C., Kogel D. and Deller T. (2010) sAPPalpha antagonizes dendritic degeneration and neuron death triggered by proteasomal stress. Mol. Cell. Neurosci. 44, 386393.
  • Davis-Salinas J., Saporito-Irwin S. M., Donovan F. M., Cunningham D. D. and Van Nostrand W. E. (1994) Thrombin receptor activation induces secretion and nonamyloidogenic processing of amyloid beta-protein precursor. J. Biol. Chem. 269, 2262322627.
  • De Strooper B. and Annaert W. (2010) Novel research horizons for presenilins and gamma-secretases in cell biology and disease. Annu. Rev. Cell Dev. Biol. 26, 235260.
  • Delarasse C., Auger R., Gonnord P., Fontaine B. and Kanellopoulos J. M. (2011) The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein. J. Biol. Chem. 286, 25962606.
  • Diaz-Rodriguez E., Montero J. C., Esparis-Ogando A., Yuste L. and Pandiella A. (2002) Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding. Mol. Biol. Cell 13, 20312044.
  • Dickson D. W. (2009) Neuropathology of non-Alzheimer degenerative disorders. Int. J. Clin. Exp. Pathol. 3(1), 123.
  • Doedens J. R. and Black R. A. (2000) Stimulation-induced down-regulation of tumor necrosis factor-alpha converting enzyme. J. Biol. Chem. 275, 1459814607.
  • Duyckaerts C., Delatour B. and Potier M. C. (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 118, 536.
  • Edwards D. R., Handsley M. M. and Pennington C. J. (2008) The ADAM metalloproteinases. Mol. Aspects Med. 29, 258289.
  • Epis R., Marcello E., Gardoni F. et al. (2010) Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer’s disease. Brain 133, 33233335.
  • Esch F. S., Keim P. S., Beattie E. C., Blacher R. W., Culwell A. R., Oltersdorf T., McClure D. and Ward P. J. (1990) Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 248, 11221124.
  • Faure J., Lachenal G., Court M. et al. (2006) Exosomes are released by cultured cortical neurones. Mol. Cell. Neurosci. 31, 642648.
  • Fellgiebel A., Kojro E., Muller M. J., Scheurich A., Schmidt L. G. and Fahrenholz F. (2009) CSF APPs alpha and phosphorylated tau protein levels in mild cognitive impairment and dementia of Alzheimer’s type. J. Geriatr. Psychiatry Neurol. 22, 39.
  • Fevrier B. and Raposo G. (2004) Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr. Opin. Cell Biol. 16, 415421.
  • Furukawa K. and Mattson M. P. (1998) Secreted amyloid precursor protein alpha selectively suppresses N-methyl-D-aspartate currents in hippocampal neurons: involvement of cyclic GMP. Neuroscience 83, 429438.
  • Furukawa K., Barger S. W., Blalock E. M. and Mattson M. P. (1996a) Activation of K+ channels and suppression of neuronal activity by secreted beta-amyloid-precursor protein. Nature 379, 7478.
  • Furukawa K., Sopher B. L., Rydel R. E., Begley J. G., Pham D. G., Martin G. M., Fox M. and Mattson M. P. (1996b) Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J. Neurochem. 67, 18821896.
  • Georgakopoulos A., Marambaud P., Efthimiopoulos S. et al. (1999) Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts. Mol. Cell 4, 893902.
  • Georgakopoulos A., Litterst C., Ghersi E., Baki L., Xu C., Serban G. and Robakis N. K. (2006) Metalloproteinase/presenilin1 processing of ephrinB regulates EphB-induced Src phosphorylation and signaling. EMBO J. 25, 12421252.
  • Giulian D., Haverkamp L. J., Yu J., Karshin W., Tom D., Li J., Kazanskaia A., Kirkpatrick J. and Roher A. E. (1998) The HHQK domain of beta-amyloid provides a structural basis for the immunopathology of Alzheimer’s disease. J. Biol. Chem. 273, 2971929726.
  • Golde T. E., Petrucelli L. and Lewis J. (2010) Targeting Abeta and tau in Alzheimer’s disease, an early interim report. Exp. Neurol. 223, 252266.
  • Gralle M., Botelho M. G. and Wouters F. S. (2009) Neuroprotective secreted amyloid precursor protein acts by disrupting amyloid precursor protein dimers. J. Biol. Chem. 284, 1501615025.
  • Hartmann D., de Strooper B., Serneels L. et al. (2002) The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Hum. Mol. Genet. 112, 26152624.
  • Higashi S. and Miyazaki K. (2003) Novel processing of beta-amyloid precursor protein catalyzed by membrane type 1 matrix metalloproteinase releases a fragment lacking the inhibitor domain against gelatinase A. Biochemistry 422, 65146526.
  • Hoe H. S., Cooper M. J., Burns M. P., Lewis P. A., van der Brug M., Chakraborty G., Cartagena C. M., Pak D. T., Cookson M. R. and Rebeck G. W. (2007) The metalloprotease inhibitor TIMP-3 regulates amyloid precursor protein and apolipoprotein E receptor proteolysis. J. Neurosci. 274, 1089510905.
  • Hooper N. M., Keen J., Pappin D. J. and Turner A. J. (1987) Pig kidney angiotensin converting enzyme. Purification and characterization of amphipathic and hydrophilic forms of the enzyme establishes C-terminal anchorage to the plasma membrane. Biochem. J. 247, 8593.
  • Horiuchi K., Le Gall S., Schulte M., Yamaguchi T., Reiss K., Murphy G., Toyama Y., Hartmann D., Saftig P. and Blobel C. P. (2007) Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx. Mol. Biol. Cell 18, 176188.
  • Hung A. Y., Haass C., Nitsch R. M., Qiu W. Q., Citron M., Wurtman R. J., Growdon J. H. and Selkoe D. J. (1993) Activation of protein kinase C inhibits cellular production of the amyloid beta-protein. J. Biol. Chem. 268, 2295922962.
  • Hwang E. M., Kim S. K., Sohn J. H., Lee J. Y., Kim Y., Kim Y. S. and Mook-Jung I. (2006) Furin is an endogenous regulator of alpha-secretase associated APP processing. Biochem. Biophys. Res. Commun. 349, 654659.
  • Jacobsen K. T., Adlerz L., Multhaup G. and Iverfeldt K. (2010) Insulin-like growth factor-1 (IGF-1)-induced processing of amyloid-beta precursor protein (APP) and APP-like protein 2 is mediated by different metalloproteinases. J. Biol. Chem. 285, 1022310231.
  • Janes P. W., Saha N., Barton W. A., Kolev M. V., Wimmer-Kleikamp S. H., Nievergall E., Blobel C. P., Himanen J. P., Lackmann M. and Nikolov D. B. (2005) Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell 123, 291304.
  • Jin L. W., Ninomiya H., Roch J. M., Schubert D., Masliah E., Otero D. A. and Saitoh T. (1994) Peptides containing the RERMS sequence of amyloid beta/A4 protein precursor bind cell surface and promote neurite extension. J. Neurosci. 14, 54615470.
  • Jorissen E., Prox J., Bernreuther C. et al. (2010) The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex. J. Neurosci. 301, 48334844.
  • Kamenetz F., Tomita T., Hsieh H., Seabrook G., Borchelt D., Iwatsubo T., Sisodia S. and Malinow R. (2003) APP processing and synaptic function. Neuron 37, 925937.
  • Karkkainen I., Rybnikova E., Pelto-Huikko M. and Huovila A. P. (2000) Metalloprotease-disintegrin (ADAM) genes are widely and differentially expressed in the adult CNS. Mol. Cell. Neurosci. 15, 547560.
  • Killock D. J. and Ivetic A. (2010) The cytoplasmic domains of TNFalpha-converting enzyme (TACE/ADAM17) and L-selectin are regulated differently by p38 MAPK and PKC to promote ectodomain shedding. Biochem. J. 428, 293304.
  • Kim M. L., Zhang B., Mills I. P., Milla M. E., Brunden K. R. and Lee V. M. (2008) Effects of TNFalpha-converting enzyme inhibition on amyloid beta production and APP processing in vitro and in vivo. J. Neurosci. 284, 1205212061.
  • Koike H., Tomioka S., Sorimachi H., Saido T. C., Maruyama K., Okuyama A., Fujisawa-Sehara A., Ohno S., Suzuki K. and Ishiura S. (1999) Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein. Biochem. J. 343, 371375.
  • Kojro E., Gimpl G., Lammich S., Marz W. and Fahrenholz F. (2001) Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. Proc. Natl. Acad. Sci. USA 981, 58155820.
  • Kojro E., Postina R., Buro C., Meiringer C., Gehrig-Burger K. and Fahrenholz F. (2006) The neuropeptide PACAP promotes the alpha-secretase pathway for processing the Alzheimer amyloid precursor protein. FASEB J. 20, 512514.
  • Komano H., Seeger M., Gandy S., Wang G. T., Krafft G. A. and Fuller R. S. (1998) Involvement of cell surface glycosyl-phosphatidylinositol-linked aspartyl proteases in alpha-secretase-type cleavage and ectodomain solubilization of human Alzheimer beta-amyloid precursor protein in yeast. J. Biol. Chem. 273, 3164831651.
  • Kopan R. and Ilagan M. X. (2009) The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137, 216233.
  • Kuester M., Kemmerzehl S., Dahms S. O., Roeser D. and Than M. E. (2011) The crystal structure of death receptor 6 (DR6): a potential receptor of the amyloid precursor protein (APP). J. Mol. Biol. 409, 189201.
  • Kuhn P. H., Wang H., Dislich B., Colombo A., Zeitschel U., Ellwart J. W., Kremmer E., Rossner S. and Lichtenthaler S. F. (2010) ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. EMBO J. 291, 30203032.
  • La Marca R., Cerri F., Horiuchi K., Bachi A., Feltri M. L., Wrabetz L., Blobel C. P., Quattrini A., Salzer J. L. and Taveggia C. (2011) TACE (ADAM17) inhibits Schwann cell myelination. Nat. Neurosci. 14, 857865.
  • Lachenal G., Pernet-Gallay K., Chivet M., Hemming F. J., Belly A., Bodon G., Blot B., Haase G., Goldberg Y. and Sadoul R. (2011) Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity. Mol. Cell. Neurosci. 46, 409418.
  • Lambert J. C. and Amouyel P. (2007) Genetic heterogeneity of Alzheimer’s disease: complexity and advances. Psychoneuroendocrinology 32, S62S70.
  • Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., Haass C. and Fahrenholz F. (1999) Constitutive and regulated alpha-secretase cleavage of Alzheimer’s amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. USA 96, 39223927.
  • Lannfelt L., Basun H., Wahlund L. O., Rowe B. A. and Wagner S. L. (1995) Decreased alpha-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer’s disease. Nat. Med. 1, 829832.
  • Lee R. K., Wurtman R. J., Cox A. J. and Nitsch R. M. (1995) Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors. Proc. Natl. Acad. Sci. USA 921, 80838087.
  • Lichtenthaler S. F. (2011) Alpha-secretase in Alzheimer’s disease: molecular identity, regulation and therapeutic potential. J. Neurochem. 116, 1021.
  • Lopez-Perez E., Seidah N. G. and Checler F. (1999) Proprotein convertase activity contributes to the processing of the Alzheimer’s beta-amyloid precursor protein in human cells: evidence for a role of the prohormone convertase PC7 in the constitutive alpha-secretase pathway. J. Neurochem. 73, 20562062.
  • Lopez-Perez E., Zhang Y., Frank S. J., Creemers J., Seidah N. and Checler F. (2001) Constitutive alpha-secretase cleavage of the beta-amyloid precursor protein in the furin-deficient LoVo cell line: involvement of the pro-hormone convertase 7 and the disintegrin metalloprotease ADAM10. J. Neurochem. 76, 15321539.
  • Malinverno M., Carta M., Epis R., Marcello E., Verpelli C., Cattabeni F., Sala C., Mulle C., Di Luca M. and Gardoni F. (2010) Synaptic localization and activity of ADAM10 regulate excitatory synapses through N-cadherin cleavage. J. Neurosci. 304, 1634316355.
  • Marambaud P. and Robakis N. K. (2005) Genetic and molecular aspects of Alzheimer’s disease shed light on new mechanisms of transcriptional regulation. Genes Brain Behav. 4, 134146.
  • Marambaud P., Chevallier N., Barelli H., Wilk S. and Checler F. (1997) Proteasome contributes to the alpha-secretase pathway of amyloid precursor protein in human cells. J. Neurochem. 68, 698703.
  • Marambaud P., Shioi J., Serban G. et al. (2002) A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J. 21, 19481956.
  • Marambaud P., Wen P. H., Dutt A., Shioi J., Takashima A., Siman R. and Robakis N. K. (2003) A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. Cell 114, 635645.
  • Marcello E., Gardoni F., Mauceri D. et al. (2007) Synapse-associated protein-97 mediates alpha-secretase ADAM10 trafficking and promotes its activity. J. Neurosci. 27, 16821691.
  • Marcinkiewicz M. and Seidah N. G. (2000) Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain. J. Neurochem. 75, 21332143.
  • Maretzky T., Reiss K., Ludwig A., Buchholz J., Scholz F., Proksch E., de Strooper B., Hartmann D. and Saftig P. (2005a) ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc. Natl. Acad. Sci. USA 102, 91829187.
  • Maretzky T., Schulte M., Ludwig A., Rose-John S., Blobel C., Hartmann D., Altevogt P., Saftig P. and Reiss K. (2005b) L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth. Mol. Cell. Biol. 252, 90409053.
  • Mattson M. P., Cheng B., Culwell A. R., Esch F. S., Lieberburg I. and Rydel R. E. (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron 10, 243254.
  • McDermott J. R. and Gibson A. M. (1991) The processing of Alzheimer A4/beta-amyloid protein precursor: identification of a human brain metallopeptidase which cleaves -Lys-Leu- in a model peptide. Biochem. Biophys. Res. Commun. 179, 11481154.
  • Merlos-Suarez A., Fernandez-Larrea J., Reddy P., Baselga J. and Arribas J. (1998) Pro-tumor necrosis factor-alpha processing activity is tightly controlled by a component that does not affect notch processing. J. Biol. Chem. 273, 2495524962.
  • Meziane H., Dodart J. C., Mathis C., Little S., Clemens J., Paul S. M. and Ungerer A. (1998) Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice. Proc. Natl. Acad. Sci. USA 952, 1268312688.
  • Moechars D., Lorent K., De Strooper B., Dewachter I. and Van Leuven F. (1996) Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J. 15, 12651274.
  • Moss M. L., Jin S. L., Milla M. E. et al. (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385, 733736.
  • Muraguchi T., Takegami Y., Ohtsuka T. et al. (2007) RECK modulates Notch signaling during cortical neurogenesis by regulating ADAM10 activity. Nat. Neurosci. 10, 838845.
  • Naus S., Reipschlager S., Wildeboer D., Lichtenthaler S. F., Mitterreiter S., Guan Z., Moss M. L. and Bartsch J. W. (2006) Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8. Biol. Chem. 387, 337346.
  • Nelson W. J. (2008) Regulation of cell–cell adhesion by the cadherin–catenin complex. Biochem. Soc. Trans. 36, 149155.
  • Nikolaev A., McLaughlin T., O’Leary D. D. and Tessier-Lavigne M. (2009) APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 457, 981989.
  • Nitsch R. M., Slack B. E., Wurtman R. J. and Growdon J. H. (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258, 304307.
  • Nitsch R. M., Kim C. and Growdon J. H. (1998) Vasopressin and bradykinin regulate secretory processing of the amyloid protein precursor of Alzheimer’s disease. Neurochem. Res. 23, 807814.
  • Pan D. and Rubin G. M. (1997) Kuzbanian controls proteolytic processing of Notch and mediates lateral inhibition during Drosophila and vertebrate neurogenesis. Cell 90, 271280.
  • Parkin E. and Harris B. (2009) A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10. J. Neurochem. 108, 14641479.
  • Pastor P. and Goate A. M. (2004) Molecular genetics of Alzheimer’s disease. Curr. Psychiatry Rep. 6, 125133.
  • Postina R., Schroeder A., Dewachter I. et al. (2004) A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J. Clin. Invest. 113, 14561464.
  • Quast T., Wehner S., Kirfel G., Jaeger K., De Luca M. and Herzog V. (2003) sAPP as a regulator of dendrite motility and melanin release in epidermal melanocytes and melanoma cells. FASEB J. 171, 17391741.
  • Refolo L. M., Salton S. R., Anderson J. P., Mehta P. and Robakis N. K. (1989) Nerve and epidermal growth factors induce the release of the Alzheimer amyloid precursor from PC 12 cell cultures. Biochem. Biophys. Res. Commun. 164, 664670.
  • Reiss K., Maretzky T., Ludwig A., Tousseyn T., de Strooper B., Hartmann D. and Saftig P. (2005) ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta-catenin nuclear signalling. EMBO J. 24, 742752.
  • Ring S., Weyer S. W., Kilian S. B. et al. (2007) The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice. J. Neurosci. 272, 78177826.
  • Roberts S. B., Ripellino J. A., Ingalls K. M., Robakis N. K. and Felsenstein K. M. (1994) Non-amyloidogenic cleavage of the beta-amyloid precursor protein by an integral membrane metalloendopeptidase. J. Biol. Chem. 269, 31113116.
  • Roghani M., Becherer J. D., Moss M. L., Atherton R. E., Erdjument-Bromage H., Arribas J., Blackburn R. K., Weskamp G., Tempst P. and Blobel C. P. (1999) Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity. J. Biol. Chem. 274, 35313540.
  • Rooke J., Pan D., Xu T. and Rubin G. M. (1996) KUZ, a conserved metalloprotease-disintegrin protein with two roles in Drosophila neurogenesis. Science 273, 12271231.
  • Sahin U., Weskamp G., Kelly K., Zhou H. M., Higashiyama S., Peschon J., Hartmann D., Saftig P. and Blobel C. P. (2004) Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol. 164, 769779.
  • Saitoh T., Sundsmo M., Roch J. M., Kimura N., Cole G., Schubert D., Oltersdorf T. and Schenk D. B. (1989) Secreted form of amyloid beta protein precursor is involved in the growth regulation of fibroblasts. Cell 58, 615622.
  • Sambamurti K., Sevlever D., Koothan T. et al. (1999) Glycosylphosphatidylinositol-anchored proteins play an important role in the biogenesis of the Alzheimer’s amyloid beta-protein. J. Biol. Chem. 274, 2681026814.
  • Selkoe D. J. (2001) Alzheimer’s disease: genes, proteins, and therapy. Physiol. Rev. 81, 741766.
  • Sennvik K., Fastbom J., Blomberg M., Wahlund L. O., Winblad B. and Benedikz E. (2000) Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer’s disease patients. Neurosci. Lett. 278, 169172.
  • Sisodia S. S. (1992) Beta-amyloid precursor protein cleavage by a membrane-bound protease. Proc. Natl. Acad. Sci. USA 891, 60756079.
  • Six E., Ndiaye D., Laabi Y., Brou C., Gupta-Rossi N., Israel A. and Logeat F. (2003) The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and gamma-secretase. Proc. Natl. Acad. Sci. USA 100, 76387643.
  • Skovronsky D. M., Fath S., Lee V. M. and Milla M. E. (2001) Neuronal localization of the TNFalpha converting enzyme (TACE) in brain tissue and its correlation to amyloid plaques. J. Neurobiol. 49, 4046.
  • Slack B. E., Ma L. K. and Seah C. C. (2001) Constitutive shedding of the amyloid precursor protein ectodomain is up-regulated by tumour necrosis factor-alpha converting enzyme. Biochem. J. 357, 787794.
  • Soond S. M., Everson B., Riches D. W. and Murphy G. (2005) ERK-mediated phosphorylation of Thr735 in TNFalpha-converting enzyme and its potential role in TACE protein trafficking. J. Cell Sci. 118, 23712380.
  • Srinivasan B., Wang Z., Brun-Zinkernagel A. M., Collier R. J., Black R. A., Frank S. J., Barker P. A. and Roque R. S. (2007) Photic injury promotes cleavage of p75NTR by TACE and nuclear trafficking of the p75 intracellular domain. Mol. Cell. Neurosci. 36, 449461.
  • Srour N., Lebel A., McMahon S., Fournier I., Fugere M., Day R. and Dubois C. M. (2003) TACE/ADAM-17 maturation and activation of sheddase activity require proprotein convertase activity. FEBS Lett. 554, 275283.
  • Stoeck A., Keller S., Riedle S., Sanderson M. P., Runz S., Le Naour F., Gutwein P., Ludwig A., Rubinstein E. and Altevogt P. (2006) A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. Biochem. J. 393(Pt 3), 609618.
  • Tachida Y., Nakagawa K., Saito T. et al. (2008) Interleukin-1 beta up-regulates TACE to enhance alpha-cleavage of APP in neurons: resulting decrease in Abeta production. J. Neurochem. 104, 13871393.
  • Talamagas A. A., Efthimiopoulos S., Tsilibary E. C., Figueiredo-Pereira M. E. and Tzinia A. K. (2007) Abeta(1-40)-induced secretion of matrix metalloproteinase-9 results in sAPPalpha release by association with cell surface APP. Neurobiol. Dis. 28, 304315.
  • Tanabe C., Hotoda N., Sasagawa N., Sehara-Fujisawa A., Maruyama K. and Ishiura S. (2007) ADAM19 is tightly associated with constitutive Alzheimer’s disease APP alpha-secretase in A172 cells. Biochem. Biophys. Res. Commun. 352, 111117.
  • van Tetering G., van Diest P., Verlaan I., van der Wall E., Kopan R. and Vooijs M. (2009) Metalloprotease ADAM10 is required for Notch1 site 2 cleavage. J. Biol. Chem. 284, 3101831027.
  • Tousseyn T., Thathiah A., Jorissen E. et al. (2009) ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase. J. Biol. Chem. 284, 1173811747.
  • Uemura K., Kihara T., Kuzuya A., Okawa K., Nishimoto T., Ninomiya H., Sugimoto H., Kinoshita A. and Shimohama S. (2006) Characterization of sequential N-cadherin cleavage by ADAM10 and PS1. Neurosci. Lett. 402, 278283.
  • Vaisar T., Kassim S. Y., Gomez I. G., Green P. S., Hargarten S., Gough P. J., Parks W. C., Wilson C. L., Raines E. W. and Heinecke J. W. (2009) MMP-9 sheds the beta2 integrin subunit (CD18) from macrophages. Mol. Cell Proteomics 8, 10441060.
  • Vincent B. and Checler F. (2011) alpha-Secretase in Alzheimer’s disease and beyond: mechanistic, regulation and function in the shedding of membrane proteins. Curr. Alzheimer Res. [Epub ahead of print].
  • Vingtdeux V., Hamdane M., Loyens A. et al. (2007) Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies. J. Biol. Chem. 282, 1819718205.
  • Vohra B. P., Sasaki Y., Miller B. R., Chang J., DiAntonio A. and Milbrandt J. (2010) Amyloid precursor protein cleavage-dependent and -independent axonal degeneration programs share a common nicotinamide mononucleotide adenylyltransferase 1-sensitive pathway. J. Neurosci. 304, 1372913738.
  • Walsh D. M. and Selkoe D. J. (2007) A beta oligomers – a decade of discovery. J. Neurochem. 101, 11721184.
  • Wang R., Meschia J. F., Cotter R. J. and Sisodia S. S. (1991) Secretion of the beta/A4 amyloid precursor protein. Identification of a cleavage site in cultured mammalian cells. J. Biol. Chem. 266, 1696016964.
  • Weskamp G., Cai H., Brodie T. A., Higashyama S., Manova K., Ludwig T. and Blobel C. P. (2002) Mice lacking the metalloprotease-disintegrin MDC9 (ADAM9) have no evident major abnormalities during development or adult life. Mol. Cell. Biol. 22, 15371544.